everlinQ Endovascular Access Systems Enhancements (EASE-2) Study

NCT03708562 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Kidney Diseases

Interventions

DEVICE: everlinQ endoAVF System

Sponsor

C. R. Bard